Differentiation of high-grade and low-grade gliomas using pattern analysis of long-echo single-voxel proton magnetic resonance spectroscopy ( 1H-MRS)

Neuroradiology Journal

Volumn 21, Issue 3, 2008, Pages 338-349

  Chernov, M F ^a   Ono, Y ^a   Muragaki, Y ^a   Kubo, O ^a   Nakamura, R ^a   Iseki, H ^a   Hori, T ^a   Takakura, K ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Differential diagnosis; Glioma; Proton magnetic resonance spectroscopy; Tumor grading

Indexed keywords

LIPID;

ADULT; ALGORITHM; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CLINICAL ARTICLE; CLINICAL EVALUATION; CONFIDENCE INTERVAL; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FEMALE; GLIOBLASTOMA; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIPID ANALYSIS; MALE; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 45549085991     PISSN: 19714009     EISSN: None     Source Type: Journal    
DOI: 10.1177/197140090802100308     Document Type: Article

References (32)

1. Galanaud D, Nicoli F, Chinot O et Al: Noninvasive diagnostic assessment of brain tumors using combined in vivo MR imaging and spectroscopy. Magn Reson Med 55: 1236-1245, 2006.
2. Kwock L, Smith JK, Castillo M et Al: Clinical applications of proton MR spectroscopy in oncology. Technol Cancer Res Treat 1: 17-28, 2002.
3. Floeth FW, Pauleit D, Wittsack HJ et Al: Multimodal metabolic imaging in cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy. J Neurosurg 102: 318-327, 2005.
4. Sibtain NA, Howe FA, Saunders DE: The clinical value of proton magnetic resonance spectroscopy in adult brain tumours. Clin Radiol 62: 109-119, 2007.
5. Preul MC, Caramanos Z, Collins DL et Al: Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med 2: 323-325, 1996.
6. Moller-Hartmann W, Herminghaus S, Krings T et Al: Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 44: 371-381, 2002.
7. Herminghaus S, Dierks T, Pilatus U et Al: Determination of histopathological tumor grade in neuroepithelial brain tumors by using spectral pattern analysis of in vivo spectroscopic data. J Neurosurg 98: 74-81, 2003.
8. Fountas KN, Kapsalaki EZ, Vogel RL et Al: Noninvasive histologic grading of solid astrocytomas using proton magnetic resonance spectroscopy. Stereotact Funct Neurosurg 82: 90-97, 2004.
9. Xu M, See SJ, Ng WH et Al: Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors. Neurosurgery 56: 919-926, 2005.
10. Hollingworth W, Medina LS, Lenkinski RE et Al: A systematic literature review of magnetic resonance spectroscopy for the characterization of brain tumors. AJNR Am J Neuroradiol 27: 1404-1411, 2006.
11. Spampinato MV, Smith JK, Kwock L et Al: Cerebral blood volume measurements and proton MR spectroscopy in grading of oligodendroglial tumors. Am J Roentgenol 188: 204-212, 2007.
12. Negendank WG, Sauter R, Brown TR et Al: Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 84: 449-458, 1996.
13. Falini A, Calabrese G, Origgi D et Al: Proton magnetic resonance spectroscopy and intracranial tumours: clinical perspectives. J Neurol 243: 706-714, 1996.
14. Barbarella G, Ricci R, Pirini G et Al: In vivo single voxel 1H MRS of glial brain tumors: correlation with tissue histology and in vitro MRS. Int J Oncol 12: 461-468, 1998.
15. Law M, Yang S, Wang H et Al: Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. Am J Neuroradiol 24: 1989-1998, 2003.
16. Izumiyama H, Abe T, Tanioka D et Al: Clinicopatho-logical examination of glioma by proton magnetic resonance spectroscopy background. Brain Tumor Pathol 21: 39-46, 2004.
17. Majos C, Julia-Sape M, Alonso J et Al: Brain tumor classification by proton MR spectroscopy: comparison of diagnostic accuracy at short and long TE. Am J Neuroradiol 25: 1696-1704, 2004.
18. Fayed N, Morales H, Modrego PJ et Al: Contrast/Noise ratio on conventional MRI and Choline/Creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas. Acad Radiol 13: 728-737, 2006.
19. Oshiro S, Tsugu H, Komatsu F et Al: Quantitative assessment of gliomas by proton magnetic resonance spectroscopy. Anticancer Res 27: 3757-3764, 2007.
20. Setzer M, Herminghaus S, Marquardt G et Al: Diagnostic impact of proton MR-spectroscopy versus imageguided stereotactic biopsy. Acta Neurochir 149: 379-386, 2007.
21. Zonari P, Baraldi P, Crisi G: Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging. Neuroradiology 49: 795-803, 2007.
22. Bulakbasi N, Kocaoglu M, Ors F et Al: Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors. Am J Neuroradiol 23: 225-233, 2003.
23. Chernov MF, Hayashi M, Izawa M et Al: Proton magnetic resonance spectroscopy (MRS) of metastatic brain tumors: variations of metabolic profile. Int J Clin Oncol 11: 375-384, 2006.
24. Chernov MF, Ono Y, Kubo O et Al: Comparison of 1H-MRS-detected metabolic characteristics in single metastatic brain tumors of different origin. Brain Tumor Pathol 23: 35-40, 2006.
25. Chernov M, Hayashi M, Izawa M et Al: Metabolic characteristics of intracranial metastases, detected by single-voxel proton magnetic resonance spectroscopy, are seemingly not predictive for tumor response to Gamma Knife radiosurgery. Minim Invasive Neurosurg 50: 233-238. 2007.
26. Smith JK, Kwock L, Castillo M: Effects of contrast material on single-volume proton MR spectroscopy. AJNR Am J Neuroradiol 21: 1084-1089, 2000.
27. Kleihues P, Cavenee WK: Pathology and genetics of tumours of the Nervous System. IARC Press, Lyon 2000.
28. Graves EE, Nelson SJ, Vigneron DB et Al: A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas. Neurosurgery 46: 319-328, 2000.
29. Preul MC, Caramanos Z, Villemure J-G et Al: Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy. Neurosurgery 46: 306-318, 2000.
30. Tarnawski R, Sokol M, Pieniazek P et Al: 1H-MRS in vivo predicts the early treatment outcome of postoperative radiotherapy for malignant gliomas. Int J Radiat Oncol Biol Phys 52: 1271-1276, 2002.
31. Kuznetsov YE, Caramanos Z, Antel SB et Al: Proton magnetic resonance spectroscopic imaging can predict length of survival in patients with supratentorial gliomas. Neurosurgery 53: 565-576, 2003.
32. Oh J, Henry RG, Pirzkall A et Al: Survival analysis in patients with glioblastoma multiforme: predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume. J Magn Reson Imaging 19: 546-554, 2004.